calendar
4,590 catalysts · 4,590 phase readout · 2,336 8k filing · 285 earnings · 172 phase 2 completion · 162 pdufa · 73 phase 1 completion
4,590 catalysts · 4,590 phase readout · 2,336 8k filing · 285 earnings · 172 phase 2 completion · 162 pdufa · 73 phase 1 completion
no tagged catalysts yet
Sponsor: Atlas University. Phase: NA. Conditions: Sleep Disorder (Disorder)
Sponsor: Duke University. Phase: . Conditions: Autism, Autism Spectrum Disorder
Sponsor: University Hospital, Lille. Phase: NA. Conditions: Headache
Sponsor: Vesalio. Phase: NA. Conditions: Acute Ischemic Stroke
Sponsor: Shanghai Chest Hospital. Phase: . Conditions: Neoadjuvant Chemoimmunotherapy, Robotic Pulmonary Resection, Stage IIB-III NSCLC
Sponsor: Halic University. Phase: NA. Conditions: PHYSİOTHERAPY
Sponsor: Satelia. Phase: . Conditions: Chronic Heart Failure, Type 2 Diabetes, Diabetes (DM)
Sponsor: Eastern Mediterranean University. Phase: NA. Conditions: Prediabetes / Type 2 Diabetes
Sponsor: University of California, Los Angeles. Phase: PHASE2. Conditions: Tobacco Use Disorder, Tobacco Smoking, Tobacco Dependence
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Children Born to Mothers Enrolled in the TOCOPROM Trial
Sponsor: Marcel Curlin. Phase: PHASE4. Conditions: COVID-19
Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Cancer, Occupational Therapy
Sponsor: University Hospital, Rouen. Phase: PHASE4. Conditions: Bullous Pemphigoid
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Primary or Secondary Immune Deficiency Including Immunosuppressive Therapy, Chemotherapy, HIV Infection
Sponsor: Azienda Unità Sanitaria Locale (A.U.S.L.) Ferrara, Italy. Phase: . Conditions: Periodontal Diseases, Periodontitis
Sponsor: Afimmune. Phase: PHASE2. Conditions: Sickle Cell Disease
Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Stress Disorders, Post-Traumatic
Sponsor: University of Alberta. Phase: NA. Conditions: Spasticity, Muscle
Sponsor: Antengene Biologics Limited. Phase: PHASE1. Conditions: Advanced/Metastatic Solid Tumors
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild. Phase: . Conditions: Meningioma
Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Multiple Myeloma
Sponsor: Neuro Event Labs Inc.. Phase: . Conditions: Epilepsy
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Acute Heart Failure (AHF)
Sponsor: Guy's and St Thomas' NHS Foundation Trust. Phase: NA. Conditions: Cardiac Surgery, Infection, Soft Tissue, Wound Healing, Swabs, Self Management
Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Aging
Sponsor: University Hospital Bispebjerg and Frederiksberg. Phase: PHASE4. Conditions: Bipolar II Disorder
Sponsor: Ottawa Hospital Research Institute. Phase: PHASE4. Conditions: Atrial Fibrillation
Sponsor: VA Office of Research and Development. Phase: NA. Conditions: High-Grade Early-Stage Bladder Cancer
Sponsor: Sri Ramachandra Institute of Higher Education and Research. Phase: . Conditions: Personality Type, Leadership Style, Training Status
Sponsor: Mondelēz International, Inc.. Phase: NA. Conditions: Gastrointestinal Tolerance, Healthy Population
Sponsor: AO Innovation Translation Center. Phase: . Conditions: Temporomandibular Joint Disorders
Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation, Metastatic Prostate Neuroendocrine Carcinoma, Metastatic Prostate Small Cell Neuroendocrine Carcinoma, Stage IVB Prostate Cancer AJCC v8
Sponsor: Hôpital le Vinatier. Phase: . Conditions: Cocaine Use Disorder
Sponsor: NeuroRx, Inc.. Phase: . Conditions: Bipolar Depression, Bipolar Affective Disorder
Sponsor: I.R.C.C.S. Fondazione Santa Lucia. Phase: NA. Conditions: Spinal Cord Injury
Sponsor: Assiut University. Phase: . Conditions: Inflammatory Bowel Diseases Weight Changes
Sponsor: Sydney Local Health District. Phase: NA. Conditions: Class III Malocclusion, Underbite
Sponsor: Yonsei University. Phase: PHASE2. Conditions: Neoplasms of Connective and Soft Tissue With an Unspecified Anatomical Site
Sponsor: Bristol-Myers Squibb. Phase: . Conditions: Muscle-invasive Urothelial Carcinoma
Sponsor: University of Thessaly. Phase: NA. Conditions: Obesity & Overweight
Sponsor: Southeast University, China. Phase: . Conditions: Acute Respiratory Distress Syndrome
Sponsor: Nanfang Hospital, Southern Medical University. Phase: . Conditions: Early Colorectal Cancer, Non-curative Endoscopic Resection
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Eosinophilia, Hypereosinophilic Syndrome
Sponsor: Outcome Referrals, Inc.. Phase: . Conditions: Adolescent Well-Being, Mental Disorders, Severe
Sponsor: Alexandria University. Phase: NA. Conditions: Maxillofacial Reconstruction
Sponsor: Beijing Kanova Biopharmaceutical Co., LTD. Phase: PHASE1. Conditions: Asthma
Sponsor: University of Louisville. Phase: NA. Conditions: Parkinson Disease
Sponsor: Dokuz Eylul University. Phase: NA. Conditions: Liver Transplant Disorder
Sponsor: National Institute of Environmental Health Sciences (NIEHS). Phase: . Conditions: Myositis, Dermatomyositis, Polymyositis, Juvenile Dermatomyositis, Juvenile Polymyositis
Sponsor: Prime Gene Therapeutics Co., Ltd.. Phase: PHASE1. Conditions: Lichen Simplex Chronicus